课题基金 / 基金详情

PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE

PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE
朊病毒蛋白 (PRP) 片段和朊病毒疾病
批准号:
8361684
负责人:
DAVID EISENBERG
金额:
$1.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31

项目摘要

项目成果

DAVID EISENBERG的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用资源的许多研究子项目之一。 由NIH/NCRR资助的中心拨款提供。对子项目的主要支持 子项目的首席调查员可能是由其他来源提供的, 包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能 表示该子项目使用的中心基础设施的估计数量, 不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。 人类PrP基因第129位密码子的单核苷酸多态(SNP)导致PrP第129位氨基酸由蛋氨酸变为缬氨酸,是决定PrP疾病易感性的一个因素。然而,这种效应的分子基础仍然不清楚。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
海外基金